I-Rheumatoid Arthritis Treatment kunye neNgcambu yeCatalcer

Isifundo Sifumana I-Biologics Bonisa Akukho Mngcipheko Ophezulu weCarcer Breast

Ingozi yomhlaza webele

Uphando alubonisi ubungqina bokuba namhlanje ukuba unyango lwe- rheumatoid arthritis lonyusa umngcipheko wesifo somhlaza webele, ngokukodwa amachiza amasha. I-National Databank ye-Rheumatic Diseases (NDB) inikeze uphando kwi-Congress YaseYurophu yeRheumatology eqhutywe yi-European League Against Rheumatism (EULAR) ngo-2005.

Amachiza amatsha, aziwa ngokuba yi-biologic response modifiers okanye biologics, afaka iziyobisi:

La mayeza ayenomdla okhethekileyo kuba unyango oluninzi lukhuphula umngcipheko wamanye amagciwane e-rheumatoid arthritis (RA). Ucwaningo lwangaphambili lwe-NDB lufumene umbutho phakathi kwe-biologics kunye ne-non-melanoma yomhlaza wesikhumba.

Uphando luyaqaphelisa ukuba ngenxa yokuba izidakamizwa ziye zithengiswa kwimarike iminyaka embalwa, ukunyamezela isigulane kwisifo kunokuthi kube mfutshane kakhulu kwisigqibo esiqinileyo kwaye kuya kuphinda kufundwe.

Ziziphi ii-Biologic Response Modifiers?

Iinguqu ze-biologicalic modifiers ziphakathi kwezidakamizwa ezitsha ezisetyenziselwa ukunyanga i-rheumatoid arthritis. I-Biologics yile mithi esekelwe kwiinkompo ezenziwe ngamaseli aphilayo. Ulwaphulo lwezinto eziphilayo lusebenzisa ama-modifiers e-biological response to stimulate or restore the power of system immune system ukulwa nezifo kunye / okanye usulelo. Izinto zezinto eziphilayo ziquka:

Iziyobisi ze-Enbrel, Remicade, kunye ne-Humira, zijolise kwiziphumo ze-TNF-alpha. I-TNF-alpha yenye yeyona i-cytokines ebaluleke kakhulu echaphazelekayo kwi-rheumatoid arthritis ngokusebenzisa ukungena kwayo kwi-reaction of inflammatory reaction. I-TNF blockers zibophezela kwi-TNF-alpha, iyenza ingasebenzi, kwaye iphazamise umsebenzi ovuzayo, ekugqibeleni unciphise umonakalo ohlangeneyo.

Malunga neSifundo

Uhlolisiso, olubhalwa nguDkt Fred Wolfe noKaleb Michaud, basebenzisa ibhanki yedata yesifo se-rheumatic longitudinal 16,398 yezigulane ze-rheumatoid arthritis ezingazange zikwazi umdlavuza webele xa isifundo saqala. Izigulana zalandelwa iminyaka engama-6.

Uhlolisiso alufumananga imibutho ebonakalayo ebalulekileyo phakathi komhlaza wesifuba kunye namanje, ngaphambili okanye kwixesha lokuphilisa i-RA, kuquka i-biologics kunye ne-methotrexate eqhelekileyo kunye nonyango lwe- corticosteroid . Ukongezelela, akukho miqathango yesifo esibuhlungu esanyaniswa nomhlaza wesibele. Uhlobo oluthile lokuhluka kwesifo esichaza umdlavuza webele phakathi kwezigulane ze-rheumatoid arthritis ngumdala, kunye neerhafu eziphezulu zivela phakathi kweminyaka yobudala engama-55 no-70.

Yintoni I-Cancer Isifo?

Amanqamu omhlaza wesifo sesisu anokubangela ukongamela ubomi obusongela ubomi obuqala kwizicubu zesifuba. Ngokutsho kwe-ADAM, ngaphezu kwexesha lokuphila, omnye kwabafazi abasibhozo baya kufumelwa ukuba banomdlavuza wesibele. Ukholo lwe-Addiss lubhala ntoni kwiCascer Breast? , "Uninzi lweengcingo zesifuba lukhula ngokukhawuleza kwaye ngelixa inkunzi ingabonwa, mhlawumbi ikhule iminyaka emi-5 okanye eyi-10.

Umdlavuza webele wamandulo awunayo impawu kwaye kwangaphambili i-tumor ifunyenwe, ngcono amathuba okuphila. "

Ngolwazi olungakumbi malunga neCanscer Breast:

Yintoni iNational Databank ye-Rheumatic Diseases?

I-National Databank ye-Rheumatic Diseases (NDB) yinkcazelo engenzi nzuzo databank eyenza uphando oluthile lwekliniki kwizifo ze-rheumatic. I-NDB okwangoku ifuna izigulane ezixilongo lwe- rheumatoid arthritis , i- osteoarthritis , i-fibromyalgia, i-lupus okanye nayiphi enye imeko ye-rheumatic.

Ucwaningo lwe-NDB lwenzelwe ukuphucula unyango kunye neziphumo zezi meko. I-NDB yenza iziphumo zophando ngokusebenzisana ngqo kunye nezigulane ze-rheumatology.

Izigulane zibika ngazo zonke iinkalo zokugula kwazo kwiingxelo zemigangatho engama-semi-year.

Umthombo: iNational Databank yeRheumatic Diseases, EULAR 2005 I-Press Release